ClinicalTrials.gg

Program

buagafuran

Also written as “Buagafuran” and “Buagafuran capsules, 15mg/ capsule”.

Its studies are mostly in Generalized Anxiety Disorder, led by Beijing Union Pharmaceutical Factory.

Furthest: phase 3, since Jan 7, 20244 company-led studies, 4 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Beijing Union Pharmaceutical Factory44 open or runningphase 3since Jan 7, 2024Jan 7, 2024none ahead

Also a collaborator on its studies: r-g-pharma-studies-co-ltd.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 7, 2024First studies: 2 phase 3 studies in Generalized Anxiety DisorderFirst studyNCT06243640, NCT06243614
  2. Feb 26, 20262 phase 1 studiesNCT07457203, NCT07457190

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07457203Drug Drug Interaction (DDI) · China1Not yet recruitingMay 202618
NCT07457190Generalized Anxiety Disorder · China1Not yet recruitingAug 202624
NCT06243640Generalized Anxiety Disorder · China3RecruitingJun 30, 2026504
NCT06243614Generalized Anxiety Disorder · China3RecruitingJun 30, 2026410

How it is read

Names in the registry

  • “Buagafuran”, 2 entries
  • “Buagafuran capsules, 15mg/ capsule”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.